Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.07 USD
-1.43%
Market Closed
Updated:
May 29, 2024
Vivos Therapeutics Inc
Common Shares Outstanding
|
Vivos Therapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Common Shares Outstanding
$1.8m
|
CAGR 3-Years
36%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Common Shares Outstanding
$87.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Common Shares Outstanding
$111m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Common Shares Outstanding
$1.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
Cigna Corp
NYSE:CI
|
Common Shares Outstanding
$284.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Common Shares Outstanding
$84.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
See Also
What is Vivos Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
1.8m
USD
1.8m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Common Shares Outstanding amounts to 1.8m USD.
What is Vivos Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
21%
21%
Over the last year, the Common Shares Outstanding growth was 99%. The average annual Common Shares Outstanding growth rates for Vivos Therapeutics Inc have been 36% over the past three years , 21% over the past five years .
You don't have any saved screeners yet
